Skip to main content
Erschienen in: Drugs & Aging 6/2009

01.06.2009 | Original Research Article

Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They?

A Prospective Pilot Study

verfasst von: Dr Martine T. E. Puts, Beatriz Costa-Lima, Johanne Monette, Veronique Girre, Christina Wolfson, Gerald Batist, Howard Bergman

Erschienen in: Drugs & Aging | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Prescribing for older patients is challenging and complex. Cancer patients are at a considerable increased risk of drug-related problems because they typically receive a large number of medications during their cancer treatment, both for the cancer itself and for supportive care. Few studies have examined the scope of this problem in older newly diagnosed cancer patients.

Objective

To investigate the number and severity of potential drug problems and factors associated with the occurrence of potential drug problems in older newly diagnosed cancer patients.

Methods

This prospective pilot study was conducted in newly diagnosed cancer patients aged ≥65 years recruited in the Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada. Vigilance Santé software was used to identify the presence and type of potential drug problems. Logistic regression analyses were used to identify factors associated with the presence of one or more severe or moderately severe potential drug problems.

Results

There were 112 participants with a mean age of 74.2 years, and 70% were women. A total of 103 patients (92%) were taking medications. The median number of medications per patient was 5 (interquartile range 3–9) and a total of 247 potential drug problems were identified. Sixty-four patients (62.1%) had a potential drug problem of any level of severity and 49 patients had a potential moderate/severe drug problem identified (47.6%). Two (0.8%) potential drug problems of the most severe level were identified, 122 warnings (49.4%) of all potential problems were of moderate severity and 123 warnings (49.8%) were at the least severe level. Factors associated with having one or more moderate/severe potential drug problems were taking five or more drugs and age ≥76 years.

Conclusion

The majority of older newly diagnosed cancer patients in this study were taking at least one medication and the median number of medications per patient was 5. Published studies have shown that medication problems are common in community-dwelling older persons, but they are mostly of low severity. In this group of older newly diagnosed cancer patients, potential medication problems were also found to be common; however, half of the potential problems identified were of moderate severity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370(9582): 185–91PubMedCrossRef Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370(9582): 185–91PubMedCrossRef
2.
Zurück zum Zitat Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370(9582): 173–84PubMedCrossRef Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370(9582): 173–84PubMedCrossRef
3.
Zurück zum Zitat Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 2006; 28(8): 1133–43PubMedCrossRef Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 2006; 28(8): 1133–43PubMedCrossRef
4.
Zurück zum Zitat Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61(5): 511–5PubMedCrossRef Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61(5): 511–5PubMedCrossRef
5.
Zurück zum Zitat Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5(3): 263–303PubMedCrossRef Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5(3): 263–303PubMedCrossRef
6.
Zurück zum Zitat Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63(2): 187–95PubMedCrossRef Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63(2): 187–95PubMedCrossRef
7.
Zurück zum Zitat Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31(1): 42–51PubMedCrossRef Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31(1): 42–51PubMedCrossRef
8.
Zurück zum Zitat Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54(10): 1516–23PubMedCrossRef Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54(10): 1516–23PubMedCrossRef
9.
Zurück zum Zitat Page RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006; 4(4): 297–305PubMedCrossRef Page RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006; 4(4): 297–305PubMedCrossRef
10.
Zurück zum Zitat Jano E, Aparasu RR. Healthcare outcomes associated with Beers’ criteria: a systematic review. Ann Pharmacother 2007; 41(3): 438–47PubMedCrossRef Jano E, Aparasu RR. Healthcare outcomes associated with Beers’ criteria: a systematic review. Ann Pharmacother 2007; 41(3): 438–47PubMedCrossRef
11.
Zurück zum Zitat Pugh MJ, Hanlon JT, Zeber JE, et al. Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm 2006; 12(7): 537–45PubMed Pugh MJ, Hanlon JT, Zeber JE, et al. Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm 2006; 12(7): 537–45PubMed
12.
Zurück zum Zitat Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25(4): 343–55PubMedCrossRef Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25(4): 343–55PubMedCrossRef
13.
Zurück zum Zitat Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107–16PubMedCrossRef Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107–16PubMedCrossRef
14.
Zurück zum Zitat Fu AZ, Jiang JZ, Reeves JH, et al. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care 2007; 45(5): 472–6PubMedCrossRef Fu AZ, Jiang JZ, Reeves JH, et al. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care 2007; 45(5): 472–6PubMedCrossRef
15.
Zurück zum Zitat Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116(6): 394–401PubMedCrossRef Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116(6): 394–401PubMedCrossRef
16.
Zurück zum Zitat Pugh MJ, Rosen AK, Montez-Rath M, et al. Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level. Med Care 2008; 46(2): 167–73PubMedCrossRef Pugh MJ, Rosen AK, Montez-Rath M, et al. Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level. Med Care 2008; 46(2): 167–73PubMedCrossRef
17.
Zurück zum Zitat Canadian cancer statistics 2008. Toronto (ON): Canadian Cancer Society/National Cancer Institute of Canada, 2008 Canadian cancer statistics 2008. Toronto (ON): Canadian Cancer Society/National Cancer Institute of Canada, 2008
18.
Zurück zum Zitat Blower P, de Wit R, Goodin S, et al. Drug-drug interactions in oncology: why are they important and can they be minimized? Crit Rev Oncol Hematol 2005; 55(2): 117–42PubMedCrossRef Blower P, de Wit R, Goodin S, et al. Drug-drug interactions in oncology: why are they important and can they be minimized? Crit Rev Oncol Hematol 2005; 55(2): 117–42PubMedCrossRef
19.
Zurück zum Zitat Sokol KC, Knudsen JF, Li MM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007; 32(2): 169–75PubMedCrossRef Sokol KC, Knudsen JF, Li MM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007; 32(2): 169–75PubMedCrossRef
20.
Zurück zum Zitat Riechelmann RP, Moreira F, Smaletz O, et al. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 2005; 56(3): 286–90PubMedCrossRef Riechelmann RP, Moreira F, Smaletz O, et al. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 2005; 56(3): 286–90PubMedCrossRef
21.
Zurück zum Zitat Riechelmann RP, Saad ED. A systematic review on drug interactions in oncology. Cancer Invest 2006; 24(7): 704–12PubMedCrossRef Riechelmann RP, Saad ED. A systematic review on drug interactions in oncology. Cancer Invest 2006; 24(7): 704–12PubMedCrossRef
22.
Zurück zum Zitat Riechelmann RP, Tannock IF, Wang L, et al. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007; 99(8): 592–600PubMedCrossRef Riechelmann RP, Tannock IF, Wang L, et al. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007; 99(8): 592–600PubMedCrossRef
23.
Zurück zum Zitat Riechelmann RP. Drug combinations with the potential to interact among cancer patients. Support Care Cancer 2007; 15(9): 1113–4PubMedCrossRef Riechelmann RP. Drug combinations with the potential to interact among cancer patients. Support Care Cancer 2007; 15(9): 1113–4PubMedCrossRef
24.
Zurück zum Zitat Riechelmann RP, Zimmermann C, Chin SN, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008; 35(5): 535–43PubMedCrossRef Riechelmann RP, Zimmermann C, Chin SN, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008; 35(5): 535–43PubMedCrossRef
25.
Zurück zum Zitat Tam-McDevitt J. Polypharmacy, aging, and cancer. Oncology (Williston Park) 2008; 22(9): 1052–5 Tam-McDevitt J. Polypharmacy, aging, and cancer. Oncology (Williston Park) 2008; 22(9): 1052–5
26.
Zurück zum Zitat Bierman AS, Pugh MJ, Dhalla I, et al. Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother 2007; 5(2): 147–61PubMedCrossRef Bierman AS, Pugh MJ, Dhalla I, et al. Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother 2007; 5(2): 147–61PubMedCrossRef
27.
Zurück zum Zitat Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2004; 2(1): 36–43PubMedCrossRef Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2004; 2(1): 36–43PubMedCrossRef
28.
Zurück zum Zitat Roth MT, Ivey JL. Self-reported medication use in community-residing older adults: a pilot study. Am J Geriatr Pharmacother 2005; 3(3): 196–204PubMedCrossRef Roth MT, Ivey JL. Self-reported medication use in community-residing older adults: a pilot study. Am J Geriatr Pharmacother 2005; 3(3): 196–204PubMedCrossRef
29.
Zurück zum Zitat Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58(6): 595–602PubMedCrossRef Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58(6): 595–602PubMedCrossRef
30.
Zurück zum Zitat Groll DL, Heyland DK, Caeser M, et al. Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: comparison of the Charlson Comorbidity Index and the Functional Comorbidity Index. Am J Phys Med Rehabil 2006; 85(7): 574–81PubMedCrossRef Groll DL, Heyland DK, Caeser M, et al. Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: comparison of the Charlson Comorbidity Index and the Functional Comorbidity Index. Am J Phys Med Rehabil 2006; 85(7): 574–81PubMedCrossRef
31.
Zurück zum Zitat Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146–56PubMedCrossRef Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146–56PubMedCrossRef
32.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365–76PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365–76PubMedCrossRef
33.
Zurück zum Zitat Perera S, Mody SH, Woodman RC, et al. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 2006; 54(5): 743–9PubMedCrossRef Perera S, Mody SH, Woodman RC, et al. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 2006; 54(5): 743–9PubMedCrossRef
34.
Zurück zum Zitat Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49(2): M85–94PubMedCrossRef Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49(2): M85–94PubMedCrossRef
35.
Zurück zum Zitat Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc 2003; 51(3): 314–22PubMedCrossRef Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc 2003; 51(3): 314–22PubMedCrossRef
36.
Zurück zum Zitat Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA 1999; 281(6): 558–60PubMedCrossRef Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA 1999; 281(6): 558–60PubMedCrossRef
37.
Zurück zum Zitat Rantanen T, Harris T, Leveille SG, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000; 55(3): M168–73PubMedCrossRef Rantanen T, Harris T, Leveille SG, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000; 55(3): M168–73PubMedCrossRef
38.
Zurück zum Zitat Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006; 61(1): 72–7PubMedCrossRef Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006; 61(1): 72–7PubMedCrossRef
39.
Zurück zum Zitat Davis HS, MacPherson K, Merry HR, et al. Reliability and validity of questions about exercise in the Canadian Study of Health and Aging. Int Psychogeriatr 2001; 13Suppl. 1: 177–82PubMedCrossRef Davis HS, MacPherson K, Merry HR, et al. Reliability and validity of questions about exercise in the Canadian Study of Health and Aging. Int Psychogeriatr 2001; 13Suppl. 1: 177–82PubMedCrossRef
40.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12(3): 189–98CrossRef Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12(3): 189–98CrossRef
41.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4): 695–9PubMedCrossRef Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4): 695–9PubMedCrossRef
42.
Zurück zum Zitat Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67(6): 361–70PubMedCrossRef Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67(6): 361–70PubMedCrossRef
43.
Zurück zum Zitat Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997; 42(1): 17–41PubMedCrossRef Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997; 42(1): 17–41PubMedCrossRef
44.
Zurück zum Zitat Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 1981; 36(4): 428–34PubMedCrossRef Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 1981; 36(4): 428–34PubMedCrossRef
45.
Zurück zum Zitat Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31(12): 721–7PubMed Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31(12): 721–7PubMed
46.
Zurück zum Zitat Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56(6–7): 501–9PubMedCrossRef Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56(6–7): 501–9PubMedCrossRef
47.
Zurück zum Zitat Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother 2008; 6(2): 119–29PubMedCrossRef Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother 2008; 6(2): 119–29PubMedCrossRef
48.
Zurück zum Zitat Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163(12): 1409–16PubMedCrossRef Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163(12): 1409–16PubMedCrossRef
49.
Zurück zum Zitat Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337–44PubMedCrossRef Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337–44PubMedCrossRef
50.
Zurück zum Zitat Hanigan MH, Dela Cruz BL, Thompson DM, et al. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation. J Oncol Pharm Pract 2008; 14(3): 123–30PubMedCrossRef Hanigan MH, Dela Cruz BL, Thompson DM, et al. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation. J Oncol Pharm Pract 2008; 14(3): 123–30PubMedCrossRef
51.
Zurück zum Zitat Markman M. Safety issues in using complementary and alternative medicine. J Clin Oncol 2002; 20(18 Suppl.): 39S–41SPubMed Markman M. Safety issues in using complementary and alternative medicine. J Clin Oncol 2002; 20(18 Suppl.): 39S–41SPubMed
52.
Zurück zum Zitat Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs 2004; 30(7): 33–43PubMed Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs 2004; 30(7): 33–43PubMed
53.
Zurück zum Zitat Partridge AH, Avorn J, Wang PS, et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002; 94(9): 652–61PubMedCrossRef Partridge AH, Avorn J, Wang PS, et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002; 94(9): 652–61PubMedCrossRef
54.
Zurück zum Zitat Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003; 21(4): 602–6PubMedCrossRef Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003; 21(4): 602–6PubMedCrossRef
55.
Zurück zum Zitat Partridge AH, LaFountain A, Mayer E, et al. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26(4): 556–62PubMedCrossRef Partridge AH, LaFountain A, Mayer E, et al. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26(4): 556–62PubMedCrossRef
56.
Zurück zum Zitat McCowan C, Shearer J, Donnan PT, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 2008; 99(11): 1763–8PubMedCrossRef McCowan C, Shearer J, Donnan PT, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 2008; 99(11): 1763–8PubMedCrossRef
Metadaten
Titel
Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They?
A Prospective Pilot Study
verfasst von
Dr Martine T. E. Puts
Beatriz Costa-Lima
Johanne Monette
Veronique Girre
Christina Wolfson
Gerald Batist
Howard Bergman
Publikationsdatum
01.06.2009
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 6/2009
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200926060-00008

Weitere Artikel der Ausgabe 6/2009

Drugs & Aging 6/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.